AnserBio

AnserBio is an Israeli biomedical startup developing a novel approach to cancer treatment. Our unique method of healthy p53 protein delivery into tumor cells is expected to benefit treatment of more than 60% of human cancers - alone or in combination with other agents. The company is in preclinica... Read more